OncoPep, Inc.
PrivateLast Round
Series D
Dec 9, 2021
Total Funding Raised
$17.9M
Company Overview
OncoPep, Inc. operates in Healthcare & Life Sciences and is based in North Andover, Massachusetts. Its latest recorded funding round was a Series D round in December 2021.
OncoPep, Inc. is a biotechnology company that develops targeted peptide-based cancer vaccines and immunotherapeutics for the treatment of multiple myeloma and other cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoPep, Inc. Comparables
Compare OncoPep, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Elicio Therapeutics | 79% | |
| Immatics N.V. | 78% | |
| Sellas Life Sciences Group | 77% |
For institutional investors. Book with your work email.
OncoPep, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 9, 2021 | ||||
| Series B | Aug 28, 2014 | ||||
| VC Round | Apr 26, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
OncoPep, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Leukemia & Lymphoma Society | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 9, 2021
$11M round led by Kukje Pharma and Tera Science.
- Aug 28, 2014
Raised $7M with Leukemia & Lymphoma Society participating.
For institutional investors. Book with your work email.
OncoPep, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OncoPep, Inc.'s valuation, stock price, and market status.
Is OncoPep, Inc. a public or private company?
OncoPep, Inc. is a private company.
What is the current stock price of OncoPep, Inc.?
OncoPep, Inc. is a private company, so its shares have no public market price. Caplight tracks OncoPep, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OncoPep, Inc. worth (valuation)?
Valuation information for OncoPep, Inc. is not publicly available.
Can I buy OncoPep, Inc. stock?
OncoPep, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OncoPep, Inc.'s last funding round?
OncoPep, Inc.'s most recent funding round was Series D on December 9, 2021.
Who are the main investors in OncoPep, Inc.?
Key investors in OncoPep, Inc. include Leukemia & Lymphoma Society.
Will OncoPep, Inc. IPO soon?
No public IPO plans have been announced for OncoPep, Inc..
How can I track OncoPep, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in OncoPep, Inc.'s shares on secondary markets.